RWS Completes Acolad Acquisition, Expanding Enterprise AI Reach
RWS completes its Acolad acquisition, expanding its enterprise AI capabilities and strengthening its global language technology reach.
The UK-based company adds Acolad’s enterprise customer base and specialist language services, strengthening its presence across Europe and North America.
November 2, 2026: RWS confirmed the acquisition after completing employee consultation procedures and securing regulatory approvals. According to the official RWS acquisition announcement, the transaction combines its language technology platforms with Acolad’s localization, interpreting, transcription and data services.
Key Takeaways
- Acquisition completed: RWS acquired Acogroup, Acolad’s parent company, on November 2, 2026.
- Deal value: £22.4 million enterprise value, with approximately £40.2 million in total consideration.
- Global expansion: Acolad operates across 22 countries and employs approximately 1,200 people.
- AI capabilities: The combined portfolio includes Language Weaver Pro, Trados and RWS’s Cultural Intelligence Layer.
- Industry reach: The acquisition strengthens relationships in life sciences, medical devices and regulated industries.
- Next milestone: RWS plans to provide an integration update with its December 15, 2026, financial results.
RWS Expands Enterprise AI Capabilities Through Acolad
The acquisition brings together complementary technology platforms and specialist language services for multinational enterprises managing complex content requirements.
Acolad customers will gain access to Language Weaver Pro, RWS’s AI-powered translation solution; Trados, its translation technology platform; and the Cultural Intelligence Layer, which supports linguistic and cultural accuracy in enterprise AI applications.
These technologies complement Acolad’s existing localization, interpreting, transcription and multilingual content services.
The company’s November 2 announcement emphasizes AI-powered workflows supported by specialist human oversight, particularly for organizations requiring accuracy, regulatory compliance and cultural relevance.
RWS Acquires Acolad in £40.2 Million Transaction
RWS initially announced the acquisition agreement on August 3, 2026.
According to the original regulatory acquisition filing, the transaction carried an enterprise value of approximately £22.4 million (€26 million), with total consideration of £40.2 million (€46.6 million), including approximately £17.8 million in cash held by the acquired business.
Headquartered in the Paris region, Acolad reported approximately £182 million in revenue and £13 million in adjusted EBITDA for 2025.
The company operates across 22 countries and serves multinational enterprises, including approximately half of France’s CAC 40 companies.
Independent coverage by BusinessCloud also confirmed the transaction’s completion and Acolad’s enterprise customer footprint.
Regulated Industries Strengthen RWS’s Market Position
Acolad has established relationships across medical devices, public institutions and other regulated industries requiring specialized multilingual documentation.
Approximately half of its revenue came from regulated industries, according to RWS’s August acquisition disclosure.
These capabilities complement RWS’s existing pharmaceutical and life sciences services, potentially giving enterprise customers broader access to translation technology, localization and regulatory content expertise.
However, detailed timelines for integrating individual customer-facing technologies have not been confirmed.
RWS and Acolad Leadership Address the Acquisition
RWS Chief Executive Officer Ben Faes described the completed transaction as an opportunity to combine AI technology with specialist expertise to support customers operating internationally.
In the official completion announcement, Faes welcomed Acolad employees and emphasized the importance of human expertise alongside automation.
Acolad CEO Bertrand Gstalder welcomed the proposed combination, highlighting its potential to expand enterprise language services and AI capabilities.
“We’ve built a business focused on helping global organizations grow by combining technology with deep human expertise,” Gstalder said in Acolad’s August 3 announcement. “Together, we can give our customers access to a broader range of language and content capabilities.”
Acquisition Creates Enterprise Cross-Selling Opportunities
The acquisition expands RWS’s potential customer base for AI technologies while creating opportunities to develop existing enterprise relationships.
In its October 27 trading statement, RWS identified Acolad as part of its go-to-market strategy, citing wider European reach and cross-selling opportunities.
The combined portfolio could support customers across RWS’s Generate, Transform and Protect segments.
For commercial teams, the expanded customer base creates potential opportunities for coordinated account engagement, regional sales initiatives and product education.
RWS has not disclosed specific post-acquisition cross-selling revenue targets or announced an outsourced demand-generation program.
What Happens Next for RWS and Acolad?
Acolad will become part of RWS’s Transform segment as integration progresses.
Enterprise customers, employees, investors and technology partners will be watching developments in platform integration, service availability and operational continuity.
According to the November 2 regulatory completion filing, RWS intends to provide further integration details alongside its full-year results in December.
The company’s October trading update scheduled those results for December 15, 2026.
The acquisition broadens RWS’s enterprise customer base, technology portfolio and European market presence. Its longer-term impact will depend on integration progress and customer adoption.
